Itm Isotopen Technologien Munchen Ag

Oncobeta International Gmbh

Isotopen Technologien Munchen Ag

Tuomo Nikula

Konstantin Zhernosekov

Mark Harfensteller

Oliver Buck

Michael Schilp

Thomas Wendler

Richard Henkelmann

Maria Desantis

Cesidio Cipriani

Lisa Maria Ehrenfried

Sebastian Marx

Max Bichlmaier

Juho Nikula

Siegfried Förg

Christoph Ehlers

Julian Bernd Sonnenhol

Andreas Eursch

Andreas Türler

Raffaella Perego

A method for producing a model for the application of radiation to a body surface area of a living being for cosmetic or therapeutic purposes is provided. The method includes defining a body surface area to which radiation shall be applied; producing a model having at least one surface which has the inverted shape of the defined body surface area, so that the model is configured to fit on the defined body surface area; and providing a radioactive isotope to the model during its production or after its production. Further, the use of the model in a cosmetic treatment of the skin is provided. The model, for cosmetic or therapeutic purposes, includes a surface which has the inverted shape of a defined body surface area which shall be treated with radiation.

Model for applying radiation, method for producing the same, and use thereof

Provided is a process of producing activated particles comprisingRe-isotopes and/orRe-isotopes by irradiating non-volatile and water-insoluble starting particles comprising a rhenium compound with neutrons. Further provided is a process of producing corresponding non-volatile and water-insoluble starting particles. Further provided are respective starting particles and activated particles, respectively, and a composition comprising a plurality of activated particles. The activated particles, and the composition comprising same are suitable for use in radionuclide therapy, and for cosmetic applications.

Production of Re-188/186 particles

The present invention relates to a column chromatographic method of manufacturing non-carrier-added high-purityLu compounds for medicinal purposes. In the method in accordance with the invention a cation exchanger and a suitable chelating agent are used. With the method in accordance with the invention it is possible for the first time to provide non-carrier-added high-purityLu compounds in milligram amounts for pharmaceutical-medicinal purposes fromYb compounds irradiated with thermal neutrons, the radionuclidesLu andYb being present in an approximate mass ratio of 1:10to 1:10for purification.

[object Object]

Molecule for attaching a radioactive parent nuclide to a support, comprising at least one functional group for attaching the radioactive parent nuclide; and a molecular moiety suitable for establishing a nonpolar bond to the support.

Molecule for functionalizing a support, attachment of a radionuclide to the support and radionuclide generator for preparing the radionuclide, and preparation process

An applicator for applying a radioactive substance to a biological tissue, the applicator comprising a container for receiving the radioactive substance; an application device connectable to the container, by which the substance compound can be applied to the tissue; and at least a part of a conveying device by which the radioactive substance can be supplied from the container into the application device when the application device has been connected to the container.

Applicator for applying a radioactive substance to a biological tissue

The present invention relates to aGa generator, wherein theGe parent nuclide thereof is attached specifically to a support through a triethoxyphenyl group and continuously disintegrates toGa, the triethoxyphenyl group being covalently bound to a support material through a linker.

A therapy module for providing a diagnostic or therapeutic substance combination, including at least two containers adapted to be interconnected for taking up at least one substance, and means or part of a means for supplying a quantity of the at least one substance from one of the containers into another container of the therapy module.

Integrated pharmaceutical production, quality, assurance, and safety system (IQS)

The invention relates to an apparatus for preparing a small amount of a radioactive substance combination, including a one-part body, a mixing device integrated in the body and adapted to receive a small amount of chemical substances, and at least one receptacle integrated in the body and connected to the mixing device and adapted to hold a small amount of a chemical substance.

Growing community of inventors

Ottobrunn, Germany

Tuomo Nikula